medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2025, Number 1

<< Back Next >>

Rev Latin Infect Pediatr 2025; 38 (1)

Trends in the treatment of acute otitis media in Pediatrics in Spain. Excerpt from the update of the consensus document on AOM in Pediatrics of SEIP, SEPEAP, SEORL-CC, AEPap and SEUP

López MD

Language: Spanish
References: 26
Page: 5-10
PDF size: 217.05 Kb.


ABSTRACT

Update of the relevant points on the treatment of Acute Otitis Media (AOM) in pediatrics included in the Spanish consensus after the introduction of anti-pneumococcal vaccines. AOM is currently caused predominantly by non-typeable Haemophilus influenzae and Streptococcus pneumoniae, with an increase in non-vaccine serotypes. The treatment of AOM includes adequate analgesia, considering two approaches to antibiotic therapy depending on the clinical profile and the patient: a watchful waiting for mild-moderate cases and immediate treatment for severe cases or in children under six months of age. Amoxicillin at high doses remains the antibiotic of choice, while in severe cases or with suspicion of H. influenzae infection, the use of amoxicillin/clavulanic acid is suggested. The duration of antimicrobial treatment should be individualized, with courses of five days for children over two years of age and between 7-10 days for younger children adjusted to the clinical response. The treatment of AOM in pediatrics must be careful and adapted to the individual characteristics of each patient, and this requires active epidemiological surveillance as well as the updating and divulging of management protocols.


REFERENCES

  1. López-Martín D, Piñeiro-Pérez R, Martínez-Campos L, Ares-Álvarez J, de la Calle-Cabrera T, Jiménez-Huerta I et al. Actualización del documento de consenso sobre etiología, diagnóstico y tratamiento de la otitis media aguda y sinusitis. An Pediatr (Barc). 2023; 98 (5): 362-372.

  2. Barcilay J, Jackson MA, Tunkel D. Watchful waiting versus antibiotics for acute otitis media in pediatric patients. N Engl J Med. 2024; 391 (17): 1648-1650.

  3. Paul CR, Moreno MA. Acute otitis media. JAMA Pediatr. 2020; 174 (3): 308.

  4. de Felipe B, Obando-Pacheco P, Carazo-Gallego B, López-Martín D, Santos-Pérez JL, González-Jiménez et al. Molecular epidemiology of paediatric invasive pneumococcal disease in Andalusia, Spain. Epidemiol Infect. 2022; 150: e163.

  5. Kaur R, Morris M, Pichichero ME. Epidemiology of Acute Otitis Media in the postpneumococcal conjugate vaccine era. Pediatrics. 2018; 141: e20174067.

  6. Pumarola F, Salamanca-de la Cueva I, Sistiaga-Hernando A, García-Corbeira P, Moraga-Llop FA, Cardelús S et al. Etiología bacteriana de la otitis media aguda en España en la era de la vacuna neumocócica conjugada. An Pediatr (Barc). 2016; 85 (5): 224-231.

  7. Hullegie S, Venekam RP, van Dongen TMA, Hay AD, Moore MV, Little P et al. Prevalence and antimicrobial resistance of bacteria in children with acute otitis media and ear discharge: a systematic review. Pediatr Infect Dis J. 2021; 40 (8): 756-762.

  8. Mather MW, Drinnan M, Perry JD, Powell S, Wilson JA, Powell J. A systematic review and meta-analysis of antimicrobial resistance in paediatric acute otitis media. Int J Pediatr Otorhinolaryngol. 2019; 123: 102-109.

  9. Sempere J, Llamosí M, López-Ruiz B, del Río I, Pérez-García C, Lago D et al. Effect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with reduced susceptibility in Spain, 2004-20: a national surveillance study. Lancet Microbe. 2022; 3 (10): e744-e752. doi: 10.1016/S2666-5247(22)00127-6.

  10. Venekamp RP, Damoiseaux RA, Schilder AG. Acute otitis media in children. Am Fam Physician. 2017; 95 (2): 109-110.

  11. Sjoukes A, Venekamp RP, van de Pol AC, Hay AD, Little P, Schilder AG et al. Paracetamol (acetaminophen) or non-steroidal anti-inflammatory drugs, alone or combined, for pain relief in acute otitis media in children. Cochrane Database Syst Rev. 2023; 8 (8): CD011534.

  12. Klein JO. Microbiologic efficacy of antibacterial drugs for acute otitis media. Pediatr Infect Dis J. 1993; 12 (12): 973-975.

  13. Hersh AL, Shapiro DJ, Pavia AT, Shah SS. Antibiotic prescribing in ambulatory pediatrics in the United States. Pediatrics. 2011; 128 (6): 1053-1061.

  14. Frost HM, Becker LF, Knepper BC, Shihadeh KC, Jenkins TC. Antibiotic prescribing patterns for acute otitis media for children 2 years and older. J Pediatr. 2020; 220: 109-115.e1.

  15. Venekamp RP, Sanders SL, Glasziou PP, Del Mar CB, Rovers MM. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2015; 2015 (6): CD000219.

  16. Hoberman A, Paradise JL, Rockette HE, Shaikh N, Wald ER, Kearney DH et al. Treatment of acute otitis media in children under 2 years of age. N Engl J Med. 2011; 364 (2): 105-115.

  17. Tahtinen PA, Laine MK, Huovinen P, Jalava J, Ruuskanen O, Ruohola A. A placebo-controlled trial of antimicrobial treatment for acute otitis media. N Engl J Med 2011; 364 (2): 116-126.

  18. Pinto S, Costa J, Vaz-Carneiro A, Fernandes R. Analysis of the Cochrane Review: antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2013;1:CD000219. Acta Med Port. 2013; 26 (6): 633-636.

  19. Storch-De-Gracia P, Antoñanzas-Bernar V, Vergara-Muñoz B, Lamagrande-Casanova N, Di Campli-Zaghlul et al. Comparison of amoxicillin administered twice and three times daily in children with acute otitis media. Eur J Pediatr. 2023; 182 (12): 5599-5605.

  20. Dimo J, Poole NM. Less is more: the evidence for shorter durations of antimicrobial therapy for acute otitis media. Curr Treat Options Pediatr. 2024; 10 (4): 265-275.

  21. Pichichero ME. Short course antibiotic therapy for respiratory infections: a review of the evidence. Pediatr Infect Dis J. 2000; 19 (9): 929-937.

  22. Kozyrskyj A, Klassen TP, Moffatt M, Harvey K. Short-course antibiotics for acute otitis media. Cochrane Database Syst Rev. 2010; 2010 (9): CD001095.

  23. Hoberman A, Paradise JL, Rockette HE, Kearney DH, Bhatnagar S, Shope TR et al. Shortened antimicrobial treatment for acute otitis media in young children. N Engl J Med. 2016; 375 (25): 2446-2456.

  24. Di Mario S, Gagliotti C, Buttazzi R, Marchetti F, Dodi I, Barbieri L et al. Reducing antibiotic prescriptions in children is not associated with higher rate of complications. Eur J Pediatr. 2021; 180 (4): 1185-1192.

  25. Sánchez-Arlegui A, del Arco-Rodríguez J, de Velasco-Vázquez X, Gallego-Rodrigo M, Gangoiti I, Mintegi S. Bacterial pathogens and antimicrobial resistance in acute otitis media. An Pediatr (Engl Ed). 2024; 100 (3): 173-179.

  26. Gerber JS, Ross RK, Bryan M, Localio AR, Szymczak JE, Wasserman R et al. Association of broad- vs narrow-spectrum antibiotics with treatment failure, adverse events, and quality of life in children with acute respiratory tract infections. JAMA. 2017; 318 (23): 2325-2336.




2020     |     www.medigraphic.com